qfx

Micron Technology (MU) traffics in the lifeblood of machines-memory chips, those fragile vessels that hold the world’s ephemeral thoughts. The semiconductor realm has always been a carousel of feast and famine, its seasons dictated by the whims of demand. But now, a new alchemy stirs: high-bandwidth memory, vertical 3D stacking like the roots of some subterranean forest, nourishing AI’s insatiable hunger.

The greater fool theory, that ancient waltz of buyers and sellers pirouetting on the edge of reason, had transformed into a carnival where the music never ceased. Meme stocks became totems, and valuation metrics as obsolete as sundials in an age of atomic clocks. Yet even the most enchanted forests have their seasons, and the first frost comes not as a whisper but a shiver through the bones of the unwary. Tariffs loomed like distant thunder, and the jobs reports arrived pale as specters, whispering of storms gathering beyond the horizon.

Taiwan Semiconductor Manufacturing (TSM) has risen 35% this year. Still, its forward P/E ratio sits at 24-a number so low it might as well be printed in invisible ink. This is the company that turns silicon into miracles. Without TSMC, your phone is a paperweight. Your car is a coffin. Your AI dreams? Dust.

The retreat from pandemic-era valuations exposed vulnerabilities. Demand for Pfizer’s vaccines waned as the virus mutated into a manageable threat. Worse, key revenue drivers like Eliquis and Ibrance approach patent expiration, threatening billions in annual losses. The market’s verdict is clear: Pfizer’s past triumphs no longer justify its present price.